The Clinical Times
The Front Page of Medicine

Latest medical news · page 54

The latest headlines across every section, pulled from official and open-access sources.

Fierce Biotech · Jul 20, 2026

Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trial

A phase 3 trial of Kolon TissueGene’s cell-based gene therapy has missed its co-primary endpoints. With a second late-stage study scheduled to report data in October, the biotech is holding off on determining the next steps for the osteoarthritis candidate.

WHO · Jul 20, 2026

Road deaths fall by 21% globally but stronger action is needed to save lives

Despite the addition of more than one billion motor-vehicles to the world’s roads, the global rate of road traffic deaths declined by 21% between 2011 and 2025, according to new data released by the World Health Organization (WHO). The world has experienced profound changes in road traffic during this time with the emergence of new modes of transport and a sharp rise in motorcycle use. Despite this progress, however, road traffic crashes still claimed 1.16 million people's lives in 2025. Road traffic injuries remain the leading cause of death among children and youth aged 5–29…

FDA MedWatch · Jul 20, 2026

Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine

FOR IMMEDIATE RELEASE – July 18th, 2026 – Panoli, Gujarat, Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is voluntarily recalling four lots of Cetirizine Hydrochloride Tablets USP 5 mg to the consumer level due to cross contamination with Ranitidine.

JAMA Network Open · Jul 20, 2026

Mismatched Unrelated vs Related Donor Transplantation in Blood Cancers

This cohort study of patients with acute leukemia or myelodysplastic syndromes and/or myeloproliferative neoplasms compares clinical outcomes between matched related donor and mismatched unrelated donor transplant in the posttransplant cyclophosphamide era.

JAMA Network Open · Jul 20, 2026

Immune-Enhancing Nutrition and Outcomes After Radical Cystectomy

This randomized clinical trial assesses whether perioperative specialized immunonutrition reduces 30-day complications compared with standard oral isocaloric nutrition support among adults undergoing radical cystectomy for bladder cancer.

← NewerOlder →

Back to the live front page